Filing Details
- Accession Number:
- 0001655759-24-000133
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-12 17:34:03
- Reporting Period:
- 2023-11-08
- Accepted Time:
- 2024-11-12 17:34:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1655759 | Arvinas Inc. | ARVN | Pharmaceutical Preparations (2834) | 472566120 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1959410 | K David Loomis | C/O Arvinas, Inc. 5 Science Park, 395 Winchester Ave. New Haven CT 06511 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-11-08 | 229 | $17.05 | 8,271 | No | 4 | S | Direct | |
Common Stock | Disposition | 2024-11-07 | 231 | $27.69 | 8,040 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.